Biomarkers determining treatment interval of diabetic macular edema after initial resolution by anti-vascular endothelial growth factor.

Jaehwan ChoiSang Jin KimSe Woong KangSungsoon HwangKi Young Son

Published in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2023)

A low risk of early DME recurrence is anticipated in the eyes with foveal thinning and no intraretinal cyst when anti-VEGF injection is deferred. These predictive biomarkers can be useful for patient monitoring and determining treatment strategies for DME patients.

Keyphrases

vascular endothelial growth factor
end stage renal disease
optical coherence tomography
endothelial cells
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
single molecule
rare case